CHIP is a significant risk factor for the development of several different pathologies, such as acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN), as well as cardiovascular diseases. This evidence concerns the gene STUB1 and myelodysplastic syndrome.